Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Champlin

Showing results (11-20 of 502) with videos related to

Pageof 51
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2012
Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversiesStefan O Ciurea, Richard E Champlin
Seminars in Oncology|February 19, 2004
Nonmyeloablative stem cell transplantation for lymphomaIssa F Khouri, Richard E Champlin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresisKrishna V Komanduri, Daniel Couriel, Richard E Champlin
Blood|December 10, 2020
How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal diseasePedro Puerta-Alcalde, Richard E Champlin, Dimitrios P Kontoyiannis
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 5, 2011
Progress in haploidentical stem cell transplantationUlas D Bayraktar, Richard E Champlin, Stefan O Ciurea
Hematology/Oncology Clinics of North America|July 24, 2004
Nonmyeloablative stem cell transplantation for chronic myeloid leukemiaMuzaffar H Qazilbash, Sergio A Giralt, Richard E Champlin
Ebiomedicine|December 15, 2018
Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myelomaFatih M Uckun, Sanjive Qazi, Taner Demirer, et al.
Immunotherapy|February 15, 2012
NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantationShatha Farhan, Dean A Lee, Richard E Champlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Cutaneous manifestations of chronic graft-versus-host diseaseSharon R Hymes, Maria L Turner, Richard E Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Graft--versus--breast cancer effect by allogeneic hematopoietic stem-cell transplantation: a possible new frontierNaoto T Ueno, Elizabeth J Shpall, Richard E Champlin, et al.
Pageof 51

Showing results (11-20 of 502) with videos related to

Sort By:
Pageof 51
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2012
Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversiesStefan O Ciurea, Richard E Champlin
Seminars in Oncology|February 19, 2004
Nonmyeloablative stem cell transplantation for lymphomaIssa F Khouri, Richard E Champlin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresisKrishna V Komanduri, Daniel Couriel, Richard E Champlin
Blood|December 10, 2020
How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal diseasePedro Puerta-Alcalde, Richard E Champlin, Dimitrios P Kontoyiannis
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 5, 2011
Progress in haploidentical stem cell transplantationUlas D Bayraktar, Richard E Champlin, Stefan O Ciurea
Hematology/Oncology Clinics of North America|July 24, 2004
Nonmyeloablative stem cell transplantation for chronic myeloid leukemiaMuzaffar H Qazilbash, Sergio A Giralt, Richard E Champlin
Ebiomedicine|December 15, 2018
Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myelomaFatih M Uckun, Sanjive Qazi, Taner Demirer, et al.
Immunotherapy|February 15, 2012
NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantationShatha Farhan, Dean A Lee, Richard E Champlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Cutaneous manifestations of chronic graft-versus-host diseaseSharon R Hymes, Maria L Turner, Richard E Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Graft--versus--breast cancer effect by allogeneic hematopoietic stem-cell transplantation: a possible new frontierNaoto T Ueno, Elizabeth J Shpall, Richard E Champlin, et al.
Pageof 51